Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a simple survey improve diabetes care for teens?

NCT ID NCT06390371

Symptom relief Sponsor: Children's Mercy Hospital Kansas City Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jul 10, 2026 · Updated 3 times

Summary

This study tests a survey called Spotlight AQ that teens and young adults with type 1 diabetes fill out before their clinic visit. The survey asks about their therapy, feelings, social life, and diabetes knowledge. Doctors then use the results to guide the visit. The goal is to see if this helps lower blood sugar levels (A1c) and if patients and doctors like using it. About 60 people aged 16-25 will take part.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Spotlight AQ survey platform
What this could lead to
If it works, this survey could help doctors better address the emotional and social needs of teens with type 1 diabetes, potentially improving blood sugar control.
What could go wrong
This is a small, early-stage trial with only 60 participants. The survey may not lead to significant A1c improvements, and results may not apply to all clinics.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2024

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

16 to 25 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 16-25 years old * Patients diagnosed with T1D for at least 6 months * On any diabetes treatment * Using a Continuous Glucose Monitor (CGM) * Willing/ able to use Spotlight AQ tool * Able to give verbal assent * Patients \& parents/caregiver speak English/ Spanish fluently * Patients in the Children's Mercy Kansas City Hospital or Boston Children's Hospital network Exclusion Criteria: * \<16 years old or \>25 years old * Mental illness that could seriously reduce their ability to participate in the study * Lack of capacity * In another T1D intervention study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Type 1 diabetes mellitus are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Type 1 diabetes mellitus

Contacts and locations

Locations

  • Children's Mercy

    Kansas City, Missouri, 64111, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.